Who owns the PATIENTS CAN'T WAIT. NEITHER CAN WE. trademark?

The PATIENTS CAN'T WAIT. NEITHER CAN WE. trademark is owned by LABCORP DRUG DEVELOPMENT INC..

What class is the PATIENTS CAN'T WAIT. NEITHER CAN WE. trademark registered in?

The PATIENTS CAN'T WAIT. NEITHER CAN WE. trademark is registered in Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

What is the serial number for PATIENTS CAN'T WAIT. NEITHER CAN WE.?

The USPTO serial number for PATIENTS CAN'T WAIT. NEITHER CAN WE. is 90066400.

What is the registration number for PATIENTS CAN'T WAIT. NEITHER CAN WE.?

PATIENTS CAN'T WAIT. NEITHER CAN WE. is registered under USPTO registration number 7429611.

PAT

USPTO Trademark Record

REGISTERED

PATIENTS CAN'T WAIT. NEITHER CAN WE.

SN 90066400·Reg 7429611·Filed Jul 22, 2020

Owner LABCORP DRUG DEVELOPMENT INC.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

PATIENTS CAN'T WAIT. NEITHER CAN WE. (Serial No. 90066400), Registration No. 7429611, is a registered US trademark filed on Jul 22, 2020 by LABCORP DRUG DEVELOPMENT INC.. This trademark covers Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

early section 8: June 25, 2030

Mark Intelligence

PATIENTS CAN'T WAIT. NEITHER CAN WE. (Reg. #7429611) is a registered US trademark that has been protecting its owner, LABCORP DRUG DEVELOPMENT INC., since 2020. The mark covers Class 042 (Scientific, technology & SaaS services) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 22, 2020

SERIAL

90066400

REG#

7429611

REGISTERED

Jun 25, 2024

Owner

Applicant

LABCORP DRUG DEVELOPMENT INC.

Entity

Corporation

State

Address

210 CARNEGIE CENTER, PRINCETON, NJ, 08540-6233

Country

Attorney

NameWilliam M. Bryner

Law firm

William M. Bryner KILPATRICK TOWNSEND & STOCKTON LLP

Docket

1203506

Address

1001 WEST FOURTH STREET, WINSTON-SALEM, NC 27101, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJul 22, 2020

Serial Number90066400

Registration No.7429611

Registration DateJun 25, 2024

Status DateJun 25, 2024

Published for OppositionDec 22, 2020

Mark TypeStandard characters

Attorney Docket1203506

Status DescriptionLive and registered

Filing Signals

FILED

2020

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Aug 31, 2023

First use in commerce: Aug 31, 2023

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

First use anywhere: Aug 31, 2023

First use in commerce: Aug 31, 2023

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

43 events

REGISTERED-PRINCIPAL REGISTER

Jun 25, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jun 25, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

May 23, 2024

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

May 23, 2024

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

ASSIGNED TO EXAMINER

May 16, 2024

ASSIGNED TO EXAMINER

STATEMENT OF USE PROCESSING COMPLETE

Feb 22, 2024

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Feb 15, 2024

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Feb 15, 2024

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 25, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 5 GRANTED

Aug 24, 2023

SOU EXTENSION 5 GRANTED

SOU TEAS EXTENSION RECEIVED

Aug 15, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Aug 15, 2023

SOU EXTENSION 5 FILED

CORRECTED NOA E-MAILED

Jun 24, 2023

CORRECTED NOA E-MAILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 31, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

DIVISIONAL PROCESSING COMPLETE

May 30, 2023

DIVISIONAL PROCESSING COMPLETE

SOU EXTENSION 4 GRANTED

May 30, 2023

SOU EXTENSION 4 GRANTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Apr 25, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Mar 13, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU TEAS EXTENSION RECEIVED

Feb 16, 2023

SOU TEAS EXTENSION RECEIVED

TEAS REQUEST TO DIVIDE RECEIVED

Feb 16, 2023

TEAS REQUEST TO DIVIDE RECEIVED

DIVISIONAL REQUEST RECEIVED

Feb 16, 2023

DIVISIONAL REQUEST RECEIVED

SOU EXTENSION 4 FILED

Feb 16, 2023

SOU EXTENSION 4 FILED

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Sep 07, 2022

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 17, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 3 GRANTED

Aug 15, 2022

SOU EXTENSION 3 GRANTED

SOU TEAS EXTENSION RECEIVED

Aug 15, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Aug 15, 2022

SOU EXTENSION 3 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 18, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 16, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Feb 16, 2022

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Feb 16, 2022

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 18, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Aug 16, 2021

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Aug 16, 2021

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Aug 16, 2021

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 16, 2021

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 22, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Dec 22, 2020

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 02, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 17, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Nov 06, 2020

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Aug 19, 2020

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jul 25, 2020

NEW APPLICATION ENTERED

PATIENTS CAN'T WAIT. NEITHER CAN WE.

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by LABCORP DRUG DEVELOPMENT INC.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by William M. Bryner

Resources

Company